Nanobiotix is trading at $24.50, up 6.99%, alongside a biotech-sector rally and gains in major U.S. indexes. - No specific company announcement or catalyst was identified for October 9. - A same-day report said the Paris-listed shares rebounded as the broader index rose, with the stock deeply oversold after a steep monthly decline. - The latest company news found was the October 1 CFO appointment.